Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. The company designs and develops Generation 2 and Generation 3 headset devices, that is in clinical trials for the treatment of post-traumatic stress disorder, traumatic brain injury, and substance use disorder issues related to opiate, alcoholism and chronic pain, alzheimer’s disease, and dementia. It also licenses and sells Nexalin Device, a non-invasive, safe and virtually undetectable to the human body that can provide relief to its afflicted with mental health issues, such as anxiety and insomnia. The company is headquartered in Houston, Texas.